Salmonella-associated Deaths, Sweden, 1997–2003 by Ternhag, Anders et al.
Salmonella-
associated 
Deaths, Sweden,
1997–2003
Anders Ternhag,*† Anna Törner,* Karl Ekdahl,*†
and Johan Giesecke*†
We examined excess deaths after infection with
Salmonella in a registry-based matched cohort study of
25,060 persons infected abroad and 5,139 infected within
Sweden. The domestically infected have an increased
standardized mortality ratio, whereas those who acquired
Salmonella infection abroad had no excess risk of death.
W
e were interested in studying deaths attributable to
Salmonella infection. To avoid the problem of mis-
reporting and underreporting when using death certifi-
cates, we linked all cases of salmonellosis (with
information on country of infection) reported in Sweden to
the national civil register on reported deaths during the
years 1997–2003. The primary objective was to investigate
whether patients with a diagnosis of Salmonella infection
have a death rate from all causes that differs from that of
the general population. If so, the second objective was to
determine whether this general mortality rate in previous
cases of salmonellosis could be used as a surrogate for
Salmonella-related death rates. We would in this case
expect that any elevated death rate in the Salmonella
cohort would be highest near time of infection and then
gradually diminish and approach the general death rate in
the population. Since the patients with domestic cases and
patients who contracted the infection abroad may be 2 fun-
damentally different groups, we analyzed these 2 groups
separately.
The Study
From 1997 through 2003, a total of 30,438 cases were
reported to the Swedish Institute for Infectious Disease
Control (SMI) of which 25,060 were stated to have been
infected abroad. For 239, country of infection was
unknown, and they were excluded from the analysis. The
median age for the domestically infected salmonellosis
patients was 36 years (interquartile range 20–56 years).
For persons infected abroad, median age was 40 years
(interquartile range 25–56 years). 
For general surveillance purposes, SMI receives a file
every week from the Swedish National Tax Board with all
registered deaths that occurred during the preceding week.
This file does not contain any information on cause of
death, only the personal identification number and date of
death. These data were used to identify Salmonella-infect-
ed patients who had died after receiving that diagnosis. 
For every Salmonella-infected patient, whether they
died or recovered, follow-up time was counted from the
date of onset of illness. Risk time was accumulated until
time of death or August 1, 2004. Sex-specific and age
group–specific death rates were obtained from Statistics
Sweden and were used to calculate the number of expect-
ed deaths in the Salmonella-infected cohort. The observed
number of deaths was divided by the expected number of
deaths to produce a standardized mortality ratio (SMR).
Poisson regression was used to investigate changes in
SMR over time for different strata (expected cases
explanatory variable). Exact confidence intervals were cal-
culated, assuming that the number of deaths in each stra-
tum was Poisson distributed.
For the group of persons infected within Sweden (n =
5,139), SMR was increased during every period after
onset, falling from 5.6 during the first month to 1.4 after
>1 year (Table 1). Within each stratum for time after infec-
tion in this group, homogeneity in the results was investi-
gated by calculating separate SMRs for the age groups <14
years, 15–64 years, and >65 years (Table 2). For all time
strata, the SMR was approximately equal in all age groups.
However, <1 month after infection, SMR = 11.2 (95% con-
fidence interval [CI] 4.1–21.8) for the age group 15–64
years and 4.7 (95% CI 2.6–7.4) for the >65 age group. This
difference is not significant because of the small sample,
but the assumption that the older age group is responsible
for the elevated SMR is highly unlikely. 
For persons who had acquired their Salmonella infec-
tion abroad (n = 25,060), we found no increased deaths
compared to the general population; SMR = 0.6 (95% CI
0.2–1.2) <1 month after onset, 1.3 (95% CI 0.8–2.0) after
1–3 months, 0.6 (95% CI 0.4–0.8) after 4–12 months, and
again 0.6 (95% CI 0.5–0.7) after >1 year had passed since
the acute infection (Table 1). Instead, a significantly lower
mortality ratio is evident in this subgroup, compared to
that for the Swedish general population, for every period
after 3 months have passed since onset of illness. We also
calculated SMRs for different age groups separately for the
imported salmonellosis cases, but no obvious differences
were found between age groups. 
Among the isolates that were subtyped, S. Enteritidis
and S. Typhimurium dominated in both of the groups. S.
Dublin and S. Wirchow, which sometimes are believed to
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 12, No. 2, February 2006 337
*Swedish Institute for Infectious Disease Control, Solna, Sweden;
and †Karolinska Institutet, Stockholm, Swedenbe more pathogenic than others, constituted together ≈1%
of the isolates among persons infected within Sweden and
2.6% among persons infected abroad. 
Conclusions
Undoubtedly, not all deaths identified by linkage to the
civil registration system occurred as a result of Salmonella
infection, but the finding of a high SMR near time of infec-
tion and a steady decrease over time nevertheless indicates
that salmonellosis is a contributing factor to the increased
risk of death in this group of patients. Studies have shown
that of all persons with salmonellosis only a small propor-
tion seek medical care and thus have their case end up in
the surveillance statistics (1,2). However, patients with a
severe infection, as well as patients with a travel history
before disease onset, are more likely to seek care, receive
a diagnosis, and be included in the registry, compared to
the average salmonellosis patient (2). These 2 patient
groups differ greatly with respect to disease severity.
Generally, a surveillance system will miss the milder
domestic Salmonella cases, whereas it will tend to pick up
travel-associated cases regardless of severity. Ageneraliza-
tion of our results would be the following: SMRs for
domestic cases are more representative for severe cases in
the population, while the SMRs for travel-associated cases
are probably more representative for the milder or moder-
ate cases of salmonellosis. 
A Danish study used an approach like ours and found
that 3.1% of persons infected with salmonellae were dead
within 1 year of infection (3). In this study, 0.56% of
patients (2.1% with domestic cases and 0.24% with
imported cases) were found to have died within the same
period. That domestic cases had a more severe prognosis
could be 1 explanation for this discrepancy. In Denmark,
domestic cases constitute ≈86% of all salmonellosis cases
(4), whereas in Sweden only ≈17% of cases are reported to
be domestic. Death certificates or hospital charts have
been used in other studies to measure salmonellosis deaths
(5–7), but none of these studies have thoroughly analyzed
the interval from diagnosis to death, used any other popu-
lation group for comparing death rates, or stratified cases
according to presumed country of infection.
In the present analysis, we have not adjusted our results
for coexisting illnesses. The assumption that our domestic
cases represent a more vulnerable subpopulation is born
out by the fact that the SMR for this group remains signif-
icantly >1.0 even 1 year after the acute salmonellosis
episode.
The most plausible explanation for finding completely
different SMRs for persons infected domestically and for
those infected abroad is a “healthy traveler effect” (8). The
least healthy persons in any age group are not those who
are traveling abroad. 
Future studies on deaths due to salmonellosis should
take this healthy traveler effect into consideration and, for
domestic cases, also consider the inherent bias of any
national surveillance system to include more severe cases.
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